Peripheral Arterial Disease News and Research

RSS
Journal of Endovascular Therapy publishes latest update to TASC II guidelines

Journal of Endovascular Therapy publishes latest update to TASC II guidelines

Biosensors’ Q1 FY16 revenue reduces US$67.0M compared to US$80.2M in Q1 FY15

Biosensors’ Q1 FY16 revenue reduces US$67.0M compared to US$80.2M in Q1 FY15

BioCision, CCT to develop ThawSTAR automated cell thawing system for treatment of diabetic foot ulcers

BioCision, CCT to develop ThawSTAR automated cell thawing system for treatment of diabetic foot ulcers

Novel method predicts risk of sudden cardiac death in hemodialysis patients

Novel method predicts risk of sudden cardiac death in hemodialysis patients

Stempeutics Research granted process patent in China for novel stem-cell based drug Stempeucel

Stempeutics Research granted process patent in China for novel stem-cell based drug Stempeucel

Two radiologists win Society of Interventional Radiology Foundation Leaders in Innovation Award

Two radiologists win Society of Interventional Radiology Foundation Leaders in Innovation Award

Novel technology could improve diagnosis of peripheral arterial disease

Novel technology could improve diagnosis of peripheral arterial disease

Clinical trial results of drug-eluting stent for peripheral arterial disease presented at LINC 2015

Clinical trial results of drug-eluting stent for peripheral arterial disease presented at LINC 2015

Rose Medical Center becomes first hospital in Colorado to perform new procedure for PAD patients

Rose Medical Center becomes first hospital in Colorado to perform new procedure for PAD patients

Mount Sinai Hospital first in nation to use drug-coated balloon to open blocked arteries in the leg

Mount Sinai Hospital first in nation to use drug-coated balloon to open blocked arteries in the leg

Research opens door to potential new treatments for peripheral artery disease

Research opens door to potential new treatments for peripheral artery disease

Decision Resources expands disease-level coverage of Treatment Algorithms Insight Series

Decision Resources expands disease-level coverage of Treatment Algorithms Insight Series

Drug-eluting peripheral stent from Cook Medical selected as a top 10 game-changing health technology for 2014

Drug-eluting peripheral stent from Cook Medical selected as a top 10 game-changing health technology for 2014

Johnson & Johnson sales increase 9.1% to $19.5 billion in second quarter 2014

Johnson & Johnson sales increase 9.1% to $19.5 billion in second quarter 2014

Cordis launches SABER Catheter for treatment of patients with Peripheral Arterial Disease

Cordis launches SABER Catheter for treatment of patients with Peripheral Arterial Disease

Cook Medical introduces Zilver PTX Drug-Eluting Peripheral Stent in Canada

Cook Medical introduces Zilver PTX Drug-Eluting Peripheral Stent in Canada

Zilver® PTX® drug-eluting stent from Cook Medical receives positive one-year follow-up results

Zilver® PTX® drug-eluting stent from Cook Medical receives positive one-year follow-up results

Study shows room for improvement in medical management of women with PAD

Study shows room for improvement in medical management of women with PAD

Interarm blood pressure measurement advised for diabetic patients

Interarm blood pressure measurement advised for diabetic patients

Women who drink too many diet drinks a day more likely to have heart problems

Women who drink too many diet drinks a day more likely to have heart problems

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.